Hepatic adenyl cyclase: alterations in hormone response during treatment with a chemical carcinogen.
D000255:Adenosine Triphosphate / Q000032:analysis; D000262:Adenylyl Cyclases / Q000502:physiology*; D000818:Animals; D002247:Carbon Isotopes; D002273:Carcinogens / Q000494:pharmacology; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced / Q000201:enzymology / Q000473:pathology; D000242:Cyclic AMP / Q000032:analysis; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology*; D005449:Fluorenes / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects / Q000201:enzymology* / Q000502:physiology; D008113:Liver Neoplasms / Q000139:chemically induced / Q000201:enzymology / Q000473:pathology; D008297:Male; D051381:Rats; D014316:Tritium
D002247:Carbon Isotopes; D002273:Carcinogens; D005449:Fluorenes; D014316:Tritium; D000255:Adenosine Triphosphate; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D004837:Epinephrine